US Broker Ratings

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating a 9.26% Upside Amid Strong Growth Prospects

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands out in the biotechnology sector with its impressive market capitalization of $81.41 billion. The company, known for its innovative approaches..

Danaher Corporation (DHR) Stock Analysis: A Healthcare Giant with 6.59% Potential Upside

Danaher Corporation (NYSE: DHR), a prominent player in the healthcare sector, is capturing the attention of investors with its robust market presence in the diagnostics and..

Edwards Lifesciences (EW) Stock Analysis: Exploring a Robust 17.56% Potential Upside

Edwards Lifesciences Corporation (NYSE: EW), a titan in the healthcare sector specializing in medical devices, continues to capture investor attention with its innovative cardiovascular solutions and..

Eli Lilly (LLY) Stock Analysis: Navigating a $1.12 Trillion Market Cap in the Healthcare Sector

For investors looking to make informed decisions in the healthcare sector, Eli Lilly and Company (NYSE: LLY) presents a compelling case. With a market capitalization of..

DexCom, Inc. (DXCM) Stock Analysis: A 12% Potential Upside Awaits in the Booming Medical Device Sector

DexCom, Inc. (NASDAQ: DXCM) has positioned itself as a formidable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Uncovering a 59% Potential Upside for Savvy Investors

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is a leading biotechnology firm that continues to make waves in the healthcare sector with its innovative therapeutics based on ribonucleic..

Haleon plc (HLN) Stock Analysis: Exploring the 17.81% Upside Potential Amidst Solid Dividend Yield

Haleon plc (NYSE: HLN), a prominent player in the global healthcare sector, offers an intriguing investment opportunity with its substantial market presence, diverse product portfolio, and..

Takeda Pharmaceutical Company (TAK) Stock Analysis: A Promising 15.50% Upside with a Robust Dividend Yield

Takeda Pharmaceutical Company Limited (NYSE: TAK), a prominent Japanese entity in the healthcare sector specializing in drug manufacturing, currently stands as a compelling consideration for investors..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating a 9.83% Potential Upside in the Healthcare Sector

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $122.05..

Intuitive Surgical (ISRG) Stock Analysis: A High-Precision Bet in Healthcare with 12.15% Upside Potential

Intuitive Surgical, Inc. (NASDAQ: ISRG), a stalwart in the healthcare sector, commands a formidable presence in the medical instruments and supplies industry with a market capitalization..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential Amidst Healthcare Sector Dynamics

HCA Healthcare, Inc. (NYSE: HCA), a prominent player in the medical care facilities industry, stands out with a market capitalization of $101.79 billion. Headquartered in Nashville,..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 5.81% Dividend Yield Amidst Market Challenges

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector with a formidable market capitalization of $168.6 billion, continues to capture investor attention, not just for..

Abbott Laboratories (ABT) Stock Report: Navigating a 15% Potential Upside in the Healthcare Sector

Abbott Laboratories (NYSE: ABT) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $182.7 billion,..

Gilead Sciences, Inc. (GILD) Stock Analysis: An Investor’s Guide to Navigating the Healthcare Giant’s 2.34% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a titan in the biopharmaceutical industry, is renowned for its innovative approach to addressing unmet medical needs. With a market capitalization..

AbbVie Inc. (ABBV) Stock Analysis: Navigating High Valuation with Strategic Growth

AbbVie Inc. (NYSE: ABBV), a titan in the global biopharmaceutical landscape, commands a significant presence in the healthcare sector with a robust market capitalization of $504.37..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Powerhouse with 14% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to stand out in the biotechnology sector with its robust pipeline of innovative therapies targeting serious diseases. With a market..

Kamada Ltd. (KMDA) Stock Analysis: Unpacking a 72.41% Upside Potential in the Healthcare Sector

For investors seeking a promising opportunity in the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) presents an intriguing prospect. Based in Rehovot, Israel, Kamada specializes in the..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Potential 53% Upside Lures Investors Amid Strong Revenue Growth

Emergent BioSolutions Inc. (NYSE: EBS) is capturing investor attention with a potential upside of 53.20%, according to analyst target price ranges. This healthcare sector player, based..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 70.55% Potential Upside Amidst a Strong Buy Consensus

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector specializing in medical instruments and supplies, is drawing considerable attention from investors. The company, which..

Standard BioTools Inc. (LAB) Stock Analysis: Exploring a 105% Upside Potential

Standard BioTools Inc. (NASDAQ: LAB), a notable player in the healthcare sector, is capturing investor attention with a striking potential upside of 105.04%. This medical devices..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds